• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 28 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1131
Bacillus subtilis ATCC BS50 PTA-127287 Oct 20, 2023 FDA has no questions (in PDF) (267 kB)
  1069
Corn protein Pending
  1036
Complexation products of iron with sodium citrate Oct 6, 2022 FDA Has No Questions (in PDF) (285 kB)
  1018
Carbon monoxide Aug 11, 2022 FDA has no questions (in PDF) (254 kB)
  955
Bacillus subtilis strain BS-MB40 PTA-122264 spore preparation Mar 26, 2021 FDA has no questions (in PDF) (243 kB) Sep 11, 2023
  928
Dried Saccharomyces cerevisiae yeast fermentate May 14, 2021 FDA has no questions (in PDF) (248 kB)
  926
Soluble rice flour Jan 5, 2021 FDA has no questions (in PDF) (434 kB)
  882
Rebaudioside M Feb 2, 2020 FDA has no questions (in PDF) (479 kB)
  874
Corn protein Apr 29, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 kB)
  867
Rebaudioside M Sep 3, 2019 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (36 kB)
  789
Erythritol Feb 20, 2019 FDA has no questions (in PDF) (79 kB)
  768
Stevia leaf extract Aug 13, 2018 FDA has no questions (in PDF) (100 kB)
  682
Lecithin from canola Jul 7, 2017 FDA has no questions (in PDF) (151 kB)
  626
Steviol glycosides produced in Saccharomyces cerevisiae May 27, 2016 FDA has no questions
  599
Citrus fiber Feb 17, 2016 FDA has no questions
  553
Algal oil (40% docosahexaenoic acid) derived from Schizochytrium sp. Jun 19, 2015 FDA has no questions; some uses may require a color additive listing
  398
Vegetable oil and tall oil derived phytosterol and phytosterol ester formulations Feb 13, 2012 FDA has no questions
  377
Bifidobacterium animalis subsp. lactis strain Bf-6 Sep 29, 2011 FDA has no questions
  344
Barley fiber May 23, 2011 FDA has no questions
  326
Arachidonic acid rich oil from M. alpina strain I49-N18 Oct 24, 2010 FDA has no questions
  258
Sucromalt Feb 3, 2009 FDA has no questions
  253
Rebaudioside A purified from Stevia rebaudiana (Bertoni) Bertoni Dec 17, 2008 FDA has no questions
  243
D-Ribose
   (Resubmission of GRN 100)
Nov 10, 2008 FDA has no questions
  207
Barley fiber Dec 19, 2006 FDA has no questions
  181
Phytosterols Mar 16, 2006 FDA has no questions
  150
Glucosamine hydrochloride prepared from chitin obtained from Aspergillus niger Sep 9, 2004 At the notifier's request, FDA ceased to evaluate this notice
  100
D-Ribose Sep 3, 2002 Notice does not provide a basis for a GRAS determination
  243
  48
Vegetable oil phytosterol esters Nov 27, 2000 FDA has no questions

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-